Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland-Reference-Cited by-同舟云学术

Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland

Published:2022-05 Issue:5 Volume:32 Page:399-409
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Tscherter Anne^ORCID,Rüsch Christina T.,Baumann Dominique,Enzmann Cornelia^ORCID,Hasselmann Oswald,Jacquier David,Jung Hans H.,Kruijshaar Michelle E.,Kuehni Claudia E.^ORCID,Neuwirth Christoph^ORCID,Stettner Georg M.^ORCID,Klein Andrea,Baumann Dominique,Enzmann Cornelia,Hasselmann Oswald,Jacquier David,Jung Hans H.,Klein Andrea,Kruijshaar Michelle E.,Kuehni Claudia E.,Lötscher Nadine,Neuwirth Christoph,Ramelli Gian P.,Ripellino Paolo,Scheidegger Oliver,Stettner Georg M.,Tscherter Anne,Wille David-Alexander

Publisher

Elsevier BV

Subject

Genetics (clinical),Neurology (clinical),Neurology,Pediatrics, Perinatology and Child Health

Reference51 articles.

1. 59th ENMC international workshop: spinal muscular atrophies: recent progress and revised diagnostic criteria 17–19 April 1998, Soestduinen, The Netherlands;Zerres;Neuromuscul Disord,1999

2. Spinal muscular atrophy: diagnosis and management in a new therapeutic era;Arnold;Muscle Nerve,2015

3. Natural history of infantile-onset spinal muscular atrophy;Kolb;Ann Neurol,2017

4. 209th ENMC international workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7–9 November 2014, Heemskerk, The Netherlands;Finkel;Neuromuscul Disord,2015

5. Childhood spinal muscular atrophy: controversies and challenges;Mercuri;Lancet Neurol,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Disease-modifying Therapies on Respiratory Function in People with Neuromuscular Disorders;Sleep Medicine Clinics;2024-09

2. Nutrition outcomes of disease modifying therapies in spinal muscular atrophy: A systematic review;Muscle & Nerve;2024-08-11

3. Nusinersen Improves Motor Function in Type 2 and 3 Spinal Muscular Atrophy Patients across Time;Biomedicines;2024-08-06

4. Effect of Nusinersen on Respiratory and Bulbar Function in Children with Spinal Muscular Atrophy: Real-World Experience from a Single Center;Neuropediatrics;2024-08-05

5. Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA;Neuromuscular Disorders;2024-08